SK151799A3 - Use or a secretion vector for fertility control by oral vaccination - Google Patents

Use or a secretion vector for fertility control by oral vaccination Download PDF

Info

Publication number
SK151799A3
SK151799A3 SK1517-99A SK151799A SK151799A3 SK 151799 A3 SK151799 A3 SK 151799A3 SK 151799 A SK151799 A SK 151799A SK 151799 A3 SK151799 A3 SK 151799A3
Authority
SK
Slovakia
Prior art keywords
secretion
proteins
gene
fertility control
fragments
Prior art date
Application number
SK1517-99A
Other languages
English (en)
Slovak (sk)
Inventor
Peter Donner
Werner Goebel
Andreas Demuth
Ivaylo Gentschev
Jurgen Hess
Stefan Kaufmann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of SK151799A3 publication Critical patent/SK151799A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Farming Of Fish And Shellfish (AREA)
SK1517-99A 1997-05-07 1998-05-07 Use or a secretion vector for fertility control by oral vaccination SK151799A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19720761A DE19720761A1 (de) 1997-05-07 1997-05-07 Verfahren zur Synthese und Sekretion von zur Kontrazeption geeigneter Proteine oder Proteinfragmente durch attenuierte Salmonellen oder einen anderen Gram-negativen attenuierten Impfstamm zur Erzeugung einer oralen Vakzinierung
PCT/EP1998/002679 WO1998050067A2 (de) 1997-05-07 1998-05-07 Verwendung eines sekretionsvektors zur fertilitätskontrolle durch orale vakzinierung

Publications (1)

Publication Number Publication Date
SK151799A3 true SK151799A3 (en) 2000-06-12

Family

ID=7829783

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1517-99A SK151799A3 (en) 1997-05-07 1998-05-07 Use or a secretion vector for fertility control by oral vaccination

Country Status (18)

Country Link
EP (1) EP1015023A1 (xx)
JP (1) JP2002501507A (xx)
KR (1) KR20010012257A (xx)
CN (1) CN1255067A (xx)
AU (1) AU7910798A (xx)
BG (1) BG103850A (xx)
BR (1) BR9809244A (xx)
CA (1) CA2288602A1 (xx)
DE (1) DE19720761A1 (xx)
EE (1) EE9900516A (xx)
HU (1) HUP0002752A2 (xx)
IL (1) IL132521A0 (xx)
IS (1) IS5199A (xx)
NO (1) NO995429L (xx)
PL (1) PL336786A1 (xx)
SK (1) SK151799A3 (xx)
TR (1) TR199902671T2 (xx)
WO (1) WO1998050067A2 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10206325A1 (de) * 2002-02-14 2003-09-04 Medinnova Ges Med Innovationen Ummantelter Mikroorganismus
US6989160B2 (en) * 2002-03-19 2006-01-24 Council Of Scientific And Industrial Research Therapeutic/edible compositions comprising herbal ingredients and methods for treating hyperglycemia
CN101175859B (zh) * 2005-05-12 2013-04-03 味之素株式会社 蛋白质的生产方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2096529C (en) * 1990-11-21 2003-01-21 Roy Curtiss, Iii Recombinant avirulent salmonella antifertility vaccines
US5480799A (en) * 1993-12-10 1996-01-02 The University Of North Carolina At Chapel Hill Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope

Also Published As

Publication number Publication date
EE9900516A (et) 2000-06-15
AU7910798A (en) 1998-11-27
JP2002501507A (ja) 2002-01-15
WO1998050067A9 (de) 1999-03-25
IL132521A0 (en) 2001-03-19
BG103850A (en) 2000-05-31
WO1998050067A2 (de) 1998-11-12
BR9809244A (pt) 2000-06-27
KR20010012257A (ko) 2001-02-15
HUP0002752A2 (hu) 2000-12-28
IS5199A (is) 1999-09-28
CA2288602A1 (en) 1998-11-12
TR199902671T2 (xx) 2000-09-21
NO995429D0 (no) 1999-11-05
PL336786A1 (en) 2000-07-17
NO995429L (no) 2000-01-07
CN1255067A (zh) 2000-05-31
DE19720761A1 (de) 1998-11-12
EP1015023A1 (de) 2000-07-05
WO1998050067A3 (de) 2000-06-29

Similar Documents

Publication Publication Date Title
AU779388B2 (en) Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens
EP0848756B1 (en) Materials and methods relating to the attachment and display of substances on cell surfaces
CA2265852A1 (en) Targeting antigens to the mhc class i processing pathway with anthrax toxin fusion protein
Zhang et al. Development of recombinant ovalbumin-luteinizing hormone releasing hormone as a potential sterilization vaccine
Jinshu et al. A synthetic gonadotropin-releasing hormone (GnRH) vaccine for control of fertility and hormone dependent diseases without any adjuvant
US9920314B2 (en) Compositions for and methods of identifying antigens
EP0446313B1 (en) Fusion proteins comprising TraTp and at least one LHRH analogue
SK151799A3 (en) Use or a secretion vector for fertility control by oral vaccination
JP6316448B2 (ja) 抗原キメラ、抗原組合せ、ワクチン、それらを調製する方法、及びそれらのキット
Hardy et al. Expression of recombinant mouse sperm protein sp56 and assessment of its potential for use as an antigen in an immunocontraceptive vaccine
Martin et al. Recombinant antigen-enterotoxin A2/B chimeric mucosal immunogens differentially enhance antibody responses and B7-dependent costimulation of CD4+ T cells
Smooker et al. Fasciola: kinetics and quality of humoral responses to fatty acid binding protein and cathepsin l following delivery as DNA vaccines in mice
Gaus et al. Superantigen-induced anergy of V beta 8+ CD4+ T cells induces functional but non-proliferative T cells in vivo.
CZ393799A3 (cs) Způsob výroby orální vakcíny pro kontrolu fertility
Rock et al. Immunogenicity of a fusion protein linking the beta subunit carboxyl terminal peptide (CTP) of human chorionic gonadotropin to the B subunit of Escherichia coli heat-labile enterotoxin (LTB)
EP2281893B1 (en) System for the expression of peptides on the bacterial surface
EP1532177B1 (en) Immunomodulatory constructs and their uses
AU1471202A (en) Use of a secretion vector for fertility control by oral vaccination
Khastar et al. Production and purification of recombinant B subunit of vibrio cholerae toxin in Escherichia coli
JP6999904B2 (ja) マラリア伝播阻止型ワクチン
de Jersey et al. Antigen-specific systemic and reproductive tract antibodies in foxes immunized with Salmonella typhimuriumexpressing bacterial and sperm proteins
Nygaard Secretion and anchoring of invasin from Yersinia pseudotuberculosis in Lactobacillus plantarum
Rozell Characterization of recombinant ovalbumin-LHRH as a sterilization vaccine
Al-Zarouni Expression of Recombinant Antigen in BCG
JPH04502163A (ja) 融合タンパク質